Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee Meeting, 28247-28248 [2015-11977]
Download as PDF
<![CDATA[
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Federal Register / Vol. 80, No. 95 / Monday, May 18, 2015 / Notices
of the information to be collected; and
(d) ways to minimize the burden of the
information collection on respondents,
including through the use of automated
collection techniques or other forms of
information technology.
DATES: Consideration will be given to all
comments received by July 17, 2015.
ADDRESSES: You may submit comments,
identified by docket number and title,
by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Department of Defense, Office
of the Deputy Chief Management
Officer, Directorate of Oversight and
Compliance, Regulatory and Audit
Matters Office, 9010 Defense Pentagon,
Washington, DC 20301–9010.
Instructions: All submissions received
must include the agency name, docket
number and title for this Federal
Register document. The general policy
for comments and other submissions
from members of the public is to make
these submissions available for public
viewing on the Internet at https://
www.regulations.gov as they are
received without change, including any
personal identifiers or contact
information.
Any associated form(s) for this
collection may be located within this
same electronic docket and downloaded
for review/testing. Follow the
instructions at https://
www.regulations.gov for submitting
comments. Please submit comments on
any given form identified by docket
number, form number, and title.
FOR FURTHER INFORMATION CONTACT: To
request more information on this
proposed information collection or to
obtain a copy of the proposal and
associated collection instruments,
please write to the Defense Health
Services Systems (DHSS) Program
Executive Office (PEO), ATTN: CDR
Patrick Amersbach, Defense Health
Headquarters (DHHQ) 7700 Arlington
Boulevard, Falls Church ,VA 22042–
2902, or call 703–681–0845.
SUPPLEMENTARY INFORMATION:
Title; Associated Form; and OMB
Number: Centralized Credentials
Quality Assurance System (CCQAS);
OMB Control Number 0720–TBD.
Needs and Uses: CCQAS v2.9.11 is an
automated Tri-Service, Web-based
database containing credentialing,
privileging, risk management, and
adverse actions information on direct
healthcare providers in the MHS.
CCQAS also allows providers to apply
for privileges online. This latter
capability allows for a privileging
workflow for new providers, for
VerDate Sep<11>2014
18:52 May 15, 2015
Jkt 235001
transfers (TDY and PCS), for
modification of privileges, and for
renewal of privileges and staff
reappointment within the system.
CCQAS was CAC enforced December
2009 and as part of the Federal Health
Care Center, North Chicago, VA PIV
users gained access in October 2010. In
November 2011, CCQAS was PKI/SSO
integrated.
Affected Public: Individuals or
Households.
Annual Burden Hours: 80,000.
Number of Respondents: 40,000.
Responses per Respondent: 1.
Average Burden per Response: 2
hours.
Frequency: On occasion.
Currently, CCQAS provides
credentialing, privileging, riskmanagement and adverse actions
capabilities which support medical
quality assurance activities in the direct
care system. CCQAS is fully deployed
world-wide and is used by all Services
(Army, Navy, Air Force) and
Components (Guard, Reserve). CCQAS
serves users functioning at the facility
(defined by an individual UIC), Service,
and DoD levels. Access to CCQAS
modules and capabilities within each
module is permissions-based, so that
users have access tailored to the
functions they perform and sensitive
information receives maximal
protection. Within each module, access
control is available to the screen level.
Dated: May 13, 2015.
Aaron Siegel,
Alternate OSD Federal Register, Liaison
Officer, Department of Defense.
[FR Doc. 2015–11971 Filed 5–15–15; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary
Advisory Panel; Notice of Federal
Advisory Committee Meeting
Assistant Secretary of Defense
(Health Affairs), DoD.
ACTION: Notice of meeting.
AGENCY:
The Department of Defense is
publishing this notice to announce a
Federal Advisory Committee meeting of
the Uniform Formulary Beneficiary
Advisory Panel (hereafter referred to as
the Panel).
DATES: Thursday, June 11, 2015, from
9:00 a.m. to 1:00 p.m.
ADDRESSES: Naval Heritage Center
Theater, 701 Pennsylvania Avenue NW.,
Washington, DC 20004.
SUMMARY:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
28247
Mr.
William H. Blanche, Alternate DFO,
Uniform Formulary Beneficiary
Advisory Panel, 7700 Arlington
Boulevard, Suite 5101, Falls Church, VA
22042–5101. Telephone: (703) 681–
2890. Fax: (703) 681–1940. Email
Address: dha.ncr.healthit.mbx.baprequests@mail.mil.
SUPPLEMENTARY INFORMATION:
This meeting is being held under the
provisions of the Federal Advisory
Committee Act of 1972 (Title 5, United
States Code (U.S.C.), Appendix, as
amended) and the Government in the
Sunshine Act of 1976 (5 U.S.C. 552b, as
amended).
Purpose of Meeting: The Panel will
review and comment on
recommendations made to the Director
of Defense Health Agency, by the
Pharmacy and Therapeutics Committee,
regarding the Uniform Formulary.
FOR FURTHER INFORMATION CONTACT:
Meeting Agenda
1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews
(Comments will follow each agenda
item)
a. Newer Oral Anticoagulants and
Warfarin
b. Hepatitis Antivirals (Hepatitis C)
5. Designated Newly Approved Drugs in
Already-Reviewed Classes
6. Pertinent Utilization Management
Issues
7. Panel Discussions and Vote
Meeting Accessibility: Pursuant to 5
U.S.C. 552b, as amended, and 41 Code
of Federal Regulations (CFR) 102–3.140
through 102–3.165, and the availability
of space, this meeting is open to the
public. Seating is limited and will be
provided only to the first 220 people
signing-in. All persons must sign-in
legibly.
Administrative Work Meeting: Prior to
the public meeting, the Panel will
conduct an Administrative Work
Meeting from 8:00 a.m. to 9:00 a.m. to
discuss administrative matters of the
Panel. The Administrative Work
Meeting will be held at the Naval
Heritage Center, 701 Pennsylvania
Avenue NW., Washington, DC 20004.
Pursuant to 41 CFR 102–3.160, the
Administrative Work Meeting will be
closed to the public.
Written Statements: Pursuant to 41
CFR 102–3.140, the public or interested
organizations may submit written
statements to the membership of the
Panel at any time or in response to the
stated agenda of a planned meeting.
Written statements should be submitted
to the Panel’s Designated Federal Officer
E:\FR\FM\18MYN1.SGM
18MYN1
28248
Federal Register / Vol. 80, No. 95 / Monday, May 18, 2015 / Notices
(DFO). The DFO’s contact information
can be obtained from the General
Services Administration’s Federal
Advisory Committee Act Database at
https://facadatabase.gov/.
Written statements that do not pertain
to the scheduled meeting of the Panel
may be submitted at any time. However,
if individual comments pertain to a
specific topic being discussed at a
planned meeting, then these statements
must be submitted no later than 5
business days prior to the meeting in
question. The DFO will review all
submitted written statements and
provide copies to all the committee
members.
Public Comments: In addition to
written statements, the Panel will set
aside 1 hour for individuals or
interested groups to address the Panel.
To ensure consideration of their
comments, individuals and interested
groups should submit written
statements as outlined in this notice; but
if they still want to address the Panel,
then they will be afforded the
opportunity to register to address the
Panel. The Panel’s DFO will have a
‘‘Sign-Up Roster’’ available at the Panel
meeting for registration on a first-come,
first-serve basis. Those wishing to
address the Panel will be given no more
than 5 minutes to present their
comments, and at the end of the 1 hour
time period, no further public
comments will be accepted. Anyone
who signs-up to address the Panel, but
is unable to do so due to the time
limitation, may submit their comments
in writing; however, they must
understand that their written comments
may not be reviewed prior to the Panel’s
deliberation.
To ensure timeliness of comments for
the official record, the Panel encourages
that individuals and interested groups
consider submitting written statements
instead of addressing the Panel.
Dated: May 13, 2015.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2015–11977 Filed 5–15–15; 8:45 am]
BILLING CODE 5001–06–P
asabaliauskas on DSK5VPTVN1PROD with NOTICES
DEPARTMENT OF DEFENSE
Department of the Army
[Docket ID: USA–2015–0017]
Proposed Collection; Comment
Request
Armed Forces Medical
Examiner (AFMES), DoD.
ACTION: Notice.
AGENCY:
VerDate Sep<11>2014
18:52 May 15, 2015
Jkt 235001
In compliance with the
Paperwork Reduction Act of 1995, the
Office of the Armed Forces Repository
Specimen Samples for the Identification
or Remains (AFRSSIR), a part of the
Armed Forces Medical Examiner
System (AFMES), announces a proposed
public information collection and seeks
public comment on the provisions
thereof. Comments are invited on: (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed
information collection; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
information collection on respondents,
including through the use of automated
collection techniques or other forms of
information technology.
DATES: Consideration will be given to all
comments received by July 17, 2015.
ADDRESSES: You may submit comments,
identified by docket number and title,
by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Department of Defense, Office
of the Deputy Chief Management
Officer, Directorate of Oversight and
Compliance, Regulatory and Audit
Matters Office, 9010 Defense Pentagon,
Washington, DC 20301–9010.
Instructions: All submissions received
must include the agency name, docket
number and title for this Federal
Register document. The general policy
for comments and other submissions
from members of the public is to make
these submissions available for public
viewing on the Internet at https://
www.regulations.gov as they are
received without change, including any
personal identifiers or contact
information. Any associated form(s) for
this collection may be located within
this same electronic docket and
downloaded for review/testing. Follow
the instructions at https://
www.regulations.gov for submitting
comments. Please submit comments on
any given form identified by docket
number, form number, and title.
FOR FURTHER INFORMATION CONTACT: To
request more information on this
proposed information collection or to
obtain a copy of the proposal and
associated collection instruments,
please write to the Office of the Armed
Forces Repository of Specimen Samples
for the Identification of Remains, Armed
Forces Medical Examiner System
SUMMARY:
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
(AFMES), 115 Purple Heart Drive, Dover
AFB, DE, 19902–5051, ATTN: Mr. John
Martin, Legal Counsel, AFMES at (302)
346–8634.
SUPPLEMENTARY INFORMATION:
Title; Associated Form; and OMB
Number: Donor Specimen Card, OMB
Control Number: 0702–XXXX.
Needs and Uses: The information
collected will be used for the
identification of human remains. The
principal purpose of the information is
to identify reference specimen samples
that will routinely be stored and not
analyzed until needed for remains
identification program purposes.
Affected Public: Individuals or
Households and Federal Government.
Annual Burden Hours: 62,500.
Number of Respondents: 250,000.
Responses per Respondent: 1.
Average Burden per Response: 15
minutes.
Frequency: On Occasion.
Respondents are deploying civilian or
contractors and military personnel
family members. The principal purpose
of the collection is identify reference
specimen samples that will be stored
and not analyzed until needed for
remain identification purposes. The
donors at various military collection
points and other federal agencies
provide a blood sample which is stained
on laboratory grade blood stain card
(BSC). The identifying information on
the blood stain card provided the donor
reflects the individual’s full name,
signature, social security number (SSN),
date of birth collection date and branch
of service. The BSC is air dried and
vacuumed sealed in a poly foil pouch.
An adhesive label reflecting the donor
information and redacted (SSN) is
printed on the label, along with the
unique accession number. In the event
of the donor’s death, the blood sample
is scientifically analyzed and a DNA
profile is created. This profile is then
compared with the post-mortem sample
obtained at the autopsy for positive
identification.
Dated: May 12, 2015.
Aaron Siegel,
Alternate OSD Federal Register Liaison
Officer, Department of Defense.
[FR Doc. 2015–11857 Filed 5–15–15; 8:45 am]
BILLING CODE 5001–06–P
DEPARTMENT OF EDUCATION
Applications for New Awards;
Predominantly Black Institutions
Competitive Grant Program
Office of Postsecondary
Education, Department of Education
AGENCY:
E:\FR\FM\18MYN1.SGM
18MYN1
]]>Agencies
[Federal Register Volume 80, Number 95 (Monday, May 18, 2015)]
[Notices]
[Pages 28247-28248]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11977]
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Office of the Secretary
Uniform Formulary Beneficiary Advisory Panel; Notice of Federal
Advisory Committee Meeting
AGENCY: Assistant Secretary of Defense (Health Affairs), DoD.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The Department of Defense is publishing this notice to
announce a Federal Advisory Committee meeting of the Uniform Formulary
Beneficiary Advisory Panel (hereafter referred to as the Panel).
DATES: Thursday, June 11, 2015, from 9:00 a.m. to 1:00 p.m.
ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue NW.,
Washington, DC 20004.
FOR FURTHER INFORMATION CONTACT: Mr. William H. Blanche, Alternate DFO,
Uniform Formulary Beneficiary Advisory Panel, 7700 Arlington Boulevard,
Suite 5101, Falls Church, VA 22042-5101. Telephone: (703) 681-2890.
Fax: (703) 681-1940. Email Address: dha.ncr.health-it.mbx.baprequests@mail.mil.
SUPPLEMENTARY INFORMATION:
This meeting is being held under the provisions of the Federal
Advisory Committee Act of 1972 (Title 5, United States Code (U.S.C.),
Appendix, as amended) and the Government in the Sunshine Act of 1976 (5
U.S.C. 552b, as amended).
Purpose of Meeting: The Panel will review and comment on
recommendations made to the Director of Defense Health Agency, by the
Pharmacy and Therapeutics Committee, regarding the Uniform Formulary.
Meeting Agenda
1. Sign-In
2. Welcome and Opening Remarks
3. Public Citizen Comments
4. Scheduled Therapeutic Class Reviews (Comments will follow each
agenda item)
a. Newer Oral Anticoagulants and Warfarin
b. Hepatitis Antivirals (Hepatitis C)
5. Designated Newly Approved Drugs in Already-Reviewed Classes
6. Pertinent Utilization Management Issues
7. Panel Discussions and Vote
Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and
41 Code of Federal Regulations (CFR) 102-3.140 through 102-3.165, and
the availability of space, this meeting is open to the public. Seating
is limited and will be provided only to the first 220 people signing-
in. All persons must sign-in legibly.
Administrative Work Meeting: Prior to the public meeting, the Panel
will conduct an Administrative Work Meeting from 8:00 a.m. to 9:00 a.m.
to discuss administrative matters of the Panel. The Administrative Work
Meeting will be held at the Naval Heritage Center, 701 Pennsylvania
Avenue NW., Washington, DC 20004. Pursuant to 41 CFR 102-3.160, the
Administrative Work Meeting will be closed to the public.
Written Statements: Pursuant to 41 CFR 102-3.140, the public or
interested organizations may submit written statements to the
membership of the Panel at any time or in response to the stated agenda
of a planned meeting. Written statements should be submitted to the
Panel's Designated Federal Officer
[[Page 28248]]
(DFO). The DFO's contact information can be obtained from the General
Services Administration's Federal Advisory Committee Act Database at
https://facadatabase.gov/.
Written statements that do not pertain to the scheduled meeting of
the Panel may be submitted at any time. However, if individual comments
pertain to a specific topic being discussed at a planned meeting, then
these statements must be submitted no later than 5 business days prior
to the meeting in question. The DFO will review all submitted written
statements and provide copies to all the committee members.
Public Comments: In addition to written statements, the Panel will
set aside 1 hour for individuals or interested groups to address the
Panel. To ensure consideration of their comments, individuals and
interested groups should submit written statements as outlined in this
notice; but if they still want to address the Panel, then they will be
afforded the opportunity to register to address the Panel. The Panel's
DFO will have a ``Sign-Up Roster'' available at the Panel meeting for
registration on a first-come, first-serve basis. Those wishing to
address the Panel will be given no more than 5 minutes to present their
comments, and at the end of the 1 hour time period, no further public
comments will be accepted. Anyone who signs-up to address the Panel,
but is unable to do so due to the time limitation, may submit their
comments in writing; however, they must understand that their written
comments may not be reviewed prior to the Panel's deliberation.
To ensure timeliness of comments for the official record, the Panel
encourages that individuals and interested groups consider submitting
written statements instead of addressing the Panel.
Dated: May 13, 2015.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2015-11977 Filed 5-15-15; 8:45 am]
BILLING CODE 5001-06-P
